The global foot and ankle devices market size is calculated at USD 5.42 billion in 2025 and is predicted to surpass around USD 9.90 billion by 2034, accelerating at a CAGR of 6.94% from 2025 to 2034. The North America foot and ankle devices market size surpassed USD 2.53 billion in 2024 and is expanding at a CAGR of 6.97% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Foot and Ankle Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Foot and Ankle Devices Market Revenue and Volume, by Product
8.1.1. Bracing and Support
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Joint Implants
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Soft Tissue Orthopedic Devices
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Orthopedic Fixation
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Prosthetics
8.1.5.1. Market Revenue and Volume Forecast
9.1. Foot and Ankle Devices Market Revenue and Volume, by Application
9.1.1. Hammertoe
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Trauma
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Osteoarthritis
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Rheumatoid Arthritis
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. Neurological Disorders
9.1.5.1. Market Revenue and Volume Forecast
9.1.6. Bunions
9.1.6.1. Market Revenue and Volume Forecast
9.1.7. Osteoporosis
9.1.7.1. Market Revenue and Volume Forecast
10.1. North America
10.1.1. Market Revenue and Volume Forecast, by Product
10.1.2. Market Revenue and Volume Forecast, by Application
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, by Product
10.1.3.2. Market Revenue and Volume Forecast, by Application
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, by Product
10.1.4.2. Market Revenue and Volume Forecast, by Application
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, by Product
10.2.2. Market Revenue and Volume Forecast, by Application
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, by Product
10.2.3.2. Market Revenue and Volume Forecast, by Application
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, by Product
10.2.4.2. Market Revenue and Volume Forecast, by Application
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, by Product
10.2.5.2. Market Revenue and Volume Forecast, by Application
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, by Product
10.2.6.2. Market Revenue and Volume Forecast, by Application
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, by Product
10.3.2. Market Revenue and Volume Forecast, by Application
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, by Product
10.3.3.2. Market Revenue and Volume Forecast, by Application
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, by Product
10.3.4.2. Market Revenue and Volume Forecast, by Application
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, by Product
10.3.5.2. Market Revenue and Volume Forecast, by Application
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, by Product
10.3.6.2. Market Revenue and Volume Forecast, by Application
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, by Product
10.4.2. Market Revenue and Volume Forecast, by Application
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, by Product
10.4.3.2. Market Revenue and Volume Forecast, by Application
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, by Product
10.4.4.2. Market Revenue and Volume Forecast, by Application
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, by Product
10.4.5.2. Market Revenue and Volume Forecast, by Application
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, by Product
10.4.6.2. Market Revenue and Volume Forecast, by Application
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, by Product
10.5.2. Market Revenue and Volume Forecast, by Application
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, by Product
10.5.3.2. Market Revenue and Volume Forecast, by Application
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, by Product
10.5.4.2. Market Revenue and Volume Forecast, by Application
11.1. Stryker Corp.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Johnson & Johnson (De PuySynthes)
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Zimmer Biomet Holdings, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Smith & Nephew plc
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Ossur
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Enovis
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Acumed, LLC
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Arthrex, Inc.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Paragon 28
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Orthofix
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample